Latest Articles

Publication Date
Dr Bou Farhat on a Retrospective Study of NGS vs IHC Sensitivity for dMMR CRC and Endometrial Cancer - OncLive

Dr Bou Farhat on a Retrospective Study of NGS vs IHC Sensitivity for dMMR CRC and Endometrial Cancer OncLive

Published: May 21, 2024, 7 a.m.
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer - GlobeNewswire

eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous …

Published: May 20, 2024, 7 a.m.
Blood cancer: Man left with broken neck after delayed diagnosis - BBC.com

Blood cancer: Man left with broken neck after delayed diagnosis BBC.com

Published: May 19, 2024, 7 a.m.
CoppaFeel: Woman 'blessed' to join breast cancer charity trek - BBC.com

CoppaFeel: Woman 'blessed' to join breast cancer charity trek BBC.com

Published: May 18, 2024, 7 a.m.
Plaintiffs Seek To Dismiss Hair Relaxer Lawsuits Involving Women Not Diagnosed with Uterine, Endometrial or Ovarian Cancer - AboutLawsuits.com

Plaintiffs Seek To Dismiss Hair Relaxer Lawsuits Involving Women Not Diagnosed with Uterine, Endometrial or Ovarian Cancer AboutLawsuits.com

Published: May 15, 2024, 8:32 p.m.
Revealed: people with cancer, arthritis and amputations among 40% denied disability benefits - The Guardian

Revealed: people with cancer, arthritis and amputations among 40% denied disability benefits The Guardian

Published: May 12, 2024, 7 a.m.
Olivia Munn, 43, reveals she had a hysterectomy during her battle with breast cancer: 'I had a real breakdown' - Daily Mail

Olivia Munn, 43, reveals she had a hysterectomy during her battle with breast cancer: 'I had a real breakdown' Daily Mail

Published: May 12, 2024, 7 a.m.
Dr Corr on the Rationale for Investigating Rucaparib Maintenance in Endometrial Cancer - OncLive

Dr Corr on the Rationale for Investigating Rucaparib Maintenance in Endometrial Cancer OncLive

Published: May 10, 2024, 7 a.m.
Merck's endometrial cancer therapy fails trial - Reuters

Merck's endometrial cancer therapy fails trial Reuters

Published: May 9, 2024, 7 a.m.
Postsurgical Pembrolizumab and Chemo, With or Without Radiotherapy, Falls Short in Phase 3 Trial for Newly Diagnosed, High-Risk Endometrial Cancer - AJMC.com Managed Markets Network

Postsurgical Pembrolizumab and Chemo, With or Without Radiotherapy, Falls Short in Phase 3 Trial for Newly Diagnosed, High-Risk Endometrial Cancer AJMC.com Managed Markets Network

Published: May 9, 2024, 7 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!